AMAG PHARMACEUTICALS INC (AMAG)
Institutional ownership reported to the SEC as of Q2 2026, across 23 quarters.
1
Reporting holders
$14
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| HUNTINGTON NATIONAL BANK | $14 | 1 | 0.00% | 15q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $14 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 1 | $14 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2025 | 1 | $14 | 1 | 0 | 0 | 0 | 0.0% |
| Q3 2025 | 1 | $14 | 1 | 0 | 0 | 0 | 0.0% |
| Q2 2025 | 1 | $14 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2025 | 1 | $14 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2024 | 1 | $14 | 1 | 0 | 0 | 0 | 0.0% |
| Q3 2024 | 1 | $14 | 1 | 0 | 0 | 0 | 0.0% |
| Q2 2024 | 1 | $14 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2024 | 1 | $14 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2023 | 1 | $14 | 1 | 0 | 0 | 0 | 0.0% |
| Q3 2023 | 1 | $14 | 1 | 0 | 0 | 0 | 0.0% |
| Q2 2023 | 1 | $14 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2023 | 1 | $14 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2022 | 1 | $14 | 1 | 1 | 0 | 0 | 0.0% |
| Q3 2020 | 115 | $398.9M | 41,434,360 | 9 | 25 | 49 | 2.3% |
| Q2 2020 | 120 | $301.7M | 38,556,817 | 17 | 23 | 47 | 2.2% |
| Q1 2020 | 117 | $248.6M | 39,666,864 | 11 | 36 | 41 | 1.4% |
| Q4 2019 | 139 | $526.5M | 42,371,875 | 6 | 34 | 51 | 2.1% |
| Q3 2019 | 165 | $478.8M | 40,195,392 | 20 | 50 | 49 | 3.0% |
| Q2 2019 | 173 | $440.3M | 41,368,779 | 29 | 58 | 55 | 6.2% |
| Q1 2019 | 167 | $531.2M | 40,814,998 | 15 | 64 | 46 | 1.0% |
| Q4 2018 | 187 | $690.7M | 44,956,930 | 7 | 5 | 1 | 0.7% |